Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.07 - $2.71 $403,283 - $1.02 Million
-376,900 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$3.94 - $8.19 $157,600 - $327,600
40,000 Added 11.87%
376,900 $1.91 Million
Q1 2020

May 14, 2020

BUY
$2.36 - $9.86 $70,800 - $295,800
30,000 Added 9.78%
336,900 $1.11 Million
Q1 2019

May 14, 2019

BUY
$2.62 - $4.44 $157,200 - $266,400
60,000 Added 24.3%
306,900 $1.29 Million
Q1 2018

May 14, 2018

BUY
$3.65 - $5.2 $65,335 - $93,080
17,900 Added 7.82%
246,900 $951,000
Q3 2017

Nov 14, 2017

BUY
$3.55 - $5.25 $812,950 - $1.2 Million
229,000
229,000 $905,000

About APPLIED GENETIC TECHNOLOGIES CORP


  • Ticker AGTC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,632,200
  • Description
  • Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...
More about AGTC
Track This Portfolio

Track Altrinsic Global Advisors LLC Portfolio

Follow Altrinsic Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Altrinsic Global Advisors LLC with notifications on news.